Related Experiment Video
Updated: Jan 13, 2026

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
A multiscale screening platform for rapid GPCR variant profiling reveals color-tuned JSR1 mutants
Jonas Mühle1, Deborah Walter2, Marielouise Griebl1
1Center for Life Sciences, Laboratory of Biomolecular Research, Paul Scherrer Institute, Villigen PSI, Switzerland.
A new platform enables rapid screening of G-protein-coupled receptors (GPCRs) using a baculovirus system. This accelerates the identification of functional GPCR variants for research and drug discovery.
Area of Science:
- Biochemistry
- Structural Biology
- Molecular Biology
Background:
- Integral membrane proteins, including G-protein-coupled receptors (GPCRs), are crucial research targets but often exhibit low expression and instability.
- Current methods for producing functional GPCRs, such as the baculovirus expression system, are labor-intensive, limiting high-throughput screening.
Purpose of the Study:
- To develop an efficient platform for rapid screening and characterization of G-protein-coupled receptor (GPCR) variants.
- To overcome limitations in high-throughput screening of GPCRs for biochemical and biophysical analysis.
Main Methods:
- A modular, multiscale platform was developed for rapid high-titer baculovirus generation in 96-well suspension cultures.
- The platform supports protein expression screening, intermediate-scale expression (25-mL cultures), and mini-scale affinity purification.
- Functional assays, including UV/Vis spectroscopy, G-protein activation, and thermostability, were employed.
Main Results:
- The platform successfully screened 56 mutants of Jumping Spider Rhodopsin 1 (JSR1), selecting 30 variants for further analysis.
- High-quality UV/Vis absorption spectra were obtained for selected JSR1 variants in both inactive and active states.
- Five novel JSR1 mutants with distinct absorption maxima were identified as promising candidates for optogenetic applications.
Conclusions:
- The developed platform significantly accelerates the selection and characterization of functional GPCR variants.
- This workflow provides a valuable resource for GPCR research, enhancing efficiency and reliability in identifying candidates for drug discovery and fundamental studies.
- The platform facilitates the discovery of novel GPCR variants with potential applications in optogenetics and other functional assays.
More Related Videos
08:25Using a Fluorescent PCR-capillary Gel Electrophoresis Technique to Genotype CRISPR/Cas9-mediated Knockout Mutants in a High-throughput Format
Published on: April 8, 2017
11:35Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA
Published on: August 21, 2016
Related Concept Videos
Genetic Screens
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
In-vitro Mutagenesis